Record breaking new drug approvals

From: – June 1, 2014

Record breaking new drug approvals, a hefty product pipeline and dramatically improved R&D that has kept expenditure growth below sales growth proves that the industry is turning a new corner according to the latest edition of EvaluatePharma’s World Preview report – view infographic here (PDF).

EvaluatePharma® is the leader in consensus forecasts of leading industry analysts and analysis of the pharmaceutical and biotechnology healthcare sectors providing exclusive and trusted market intelligence into global performance to 2020.